Short communication: Plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with mycobacterium tuberculosis

QR Code

Short communication: Plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with mycobacterium tuberculosis

Immune restoration disease associated with Mycobacterium tuberculosis (TB IRD) is clinically important among HIV patients commencing antiretroviral therapy in countries where tuberculosis is endemic. Vitamin D affects dendritic cell and T cell function and the antimicrobial activity of monocytes. Pl...

Full description

Bibliographic Details
Main Authors:	Price, Patricia, Haddow, L., Affandi, J., Agarwal, U., Easterbrook, P., Elliott, J., French, M., Kumar, M., Moosa, M., Oliver, B., Singh, S., Sola, M., Saphonn, V., Vun, M.
Format:	Journal Article
Published:	2012
Online Access:	http://hdl.handle.net/20.500.11937/15523

Similar Items

Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2010)

Interferon-? and IL-5 production correlate directly in HIV patients Co-infected with mycobacterium tuberculosis with or without immune restoration disease
by: Oliver, B., et al.
Published: (2010)

Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigens.
by: Oliver, B., et al.
Published: (2012)

Pre-antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral therapy
by: Oliver, B., et al.
Published: (2013)

The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2011)

The search for a genetic factor associating with immune restoration disease in HIV patients co-infected with Mycobacterium tuberculosis
by: Affandi, J., et al.
Published: (2013)

Immune restoration disease complicating antiretroviral therapy in patients with HIV infection: Implications and solutions
by: French, M., et al.
Published: (2008)

Immune restoration diseases reflect diverse immunopathological mechanisms
by: Price, Patricia, et al.
Published: (2009)

The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy
by: Lee, S., et al.
Published: (2017)

The number and function of circulating dendritic cells may limit effector memory CD4+ T-cell responses in HIV patients responding to antiretroviral therapy
by: Fernandez, S., et al.
Published: (2008)

Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?
by: Tan, D., et al.
Published: (2009)

Plasma biomarkers in the prediction and diagnosis of tuberculosis-associated immune reconstitution inflammatory syndrome
by: French, M., et al.
Published: (2011)

CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy
by: Lim, A., et al.
Published: (2009)

Tuberculosis associated immune reconstitution inflammatory syndrome in patients infected with HIV: meningitis a potentially life threatening manifestation
by: Agarwal, U., et al.
Published: (2012)

Expansion of adaptive NK cells in HIV disease persists following combination antiretroviral therapy
by: Hearps, A., et al.
Published: (2016)

Reply to 'TLR-2 ligand lipomannan from Mycobacterium tuberculosis does not stimulate inflammatory cytokines in dendritic cells'
by: Tan, D., et al.
Published: (2012)

Mycobacterial antibody levels and immune restoration disease in HIV patients treated in South East Asia
by: Sumatoh, H., et al.
Published: (2011)

Nadir CD4 T-cell counts continue to influence interferon-? responses in HIV patients who began antiretroviral treatment with advanced immunodeficiency
by: Price, Patricia, et al.
Published: (2008)

p-Hydroxybenzoic acid synthesis in mycobacterium tuberculosis
by: Stadthagen, Gustavo, et al.
Published: (2005)

Molecular genotyping of mycobacterium tuberculosis associated with extrapulmonary tuberculosis
by: Ayub, Nur Izzah Farakhin
Published: (2015)

Persistence of Activated and Adaptive-Like NK Cells in HIV+ Individuals despite 2 Years of Suppressive Combination Antiretroviral Therapy
by: Hearps, A., et al.
Published: (2017)

CD4 + T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4 + T cells
by: Fernandez, S., et al.
Published: (2011)

Electrochemical immunosensor for detection of Mycobacterium tuberculosis
by: Mohd Azmi, Umi Zulaikha, et al.
Published: (2018)

The high frequency of autoantibodies in HIV patients declines on antiretroviral therapy
by: Bundell, C., et al.
Published: (2018)

Comparison Of Proteomes Of Avirulent Mycobacterium Tuberculosis H37Ra And Virulent Mycobacterium Tuberculosis H37Rv
by: Ang, Kai Cheen
Published: (2011)

Indoleamides are active against drug-resistant Mycobacterium tuberculosis
by: Lun, S., et al.
Published: (2013)

Construction of plasmids expressing specific genes of Mycobacterium tuberculosis: towards the development of vaccine against tuberculosis
by: Musa, Mustaffa, et al.
Published: (2001)

Coenzyme F420 biosynthesis proteins in Mycobacterium tuberculosis
by: Mohamed Rehan, Aisyah, et al.
Published: (2009)

Synthesis and evaluation of inhibitors of cell wall biosynthesis in Mycobacterium tuberculosis
by: May, Terry J.
Published: (2016)

Immunopathogenesis of hepatic flare in HIV/hepatitis b virus (Hbv)-coinfected individuals after the initiation of Hbv-active antiretroviral therapy
by: Crane, M., et al.
Published: (2009)

Modulation of the immune response to Mycobacterium tuberculosis during malaria/M. tuberculosis co-infection
by: Chukwuanukwu, Rebecca C., et al.
Published: (2016)

IL1A alleles associate with a virological response to antiretroviral therapy in HIV patients beginning therapy with advanced disease
by: Price, Patricia, et al.
Published: (2009)

Characteristics of natural killer cells in Malaysian HIV patients presenting with immune restoration disease after ART
by: Tan, D., et al.
Published: (2010)

Synthesis of Potential Mycobacterium Tuberculosis InhA Inhibitors
by: Saleem, Tabrez Ali
Published: (2023)

Kinase Targets for Mycolic Acid Biosynthesis in Mycobacterium tuberculosis.
by: Alsayed, S., et al.
Published: (2018)

Electrochemical and optical-based immunosensor for detection of Mycobacterium tuberculosis
by: Mohd Bakhori, Noremylia
Published: (2019)

Respiratory microbiome and its susceptibility to Mycobacterium tuberculosis infection
by: Semail, Noreafifah
Published: (2019)

Cloning and characterization of mycobacterium tuberculosis katG gene
by: Martin, Eugene Ray
Published: (2005)

The cloning and chcracterization of mycobacterium tuberculosis katG gene
by: Martin, Eugene Ray
Published: (2005)

Proteoliposomes from mycobacterium bovis BCG and mycobacterium smegmatis as new vaccine candidates against tuberculosis
by: Kadir, Ramlah
Published: (2016)